Skip to main content
logo
NextCell Pharma AB (STO:NXTCL)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.138
-0.034 (-2.90%)
May 21, 2026, 12:39 PM CET

NextCell Pharma AB Revenue

In the year 2025, NextCell Pharma AB had annual revenue of 9.83M SEK, down -11.13%. NextCell Pharma AB had revenue of 1.83M in the quarter ending December 31, 2025, a decrease of -41.01%.

Revenue
9.83M
Revenue Growth
+4.08%
P/S Ratio
13.28
Revenue / Employee
409.73K
Employees
24
Market Cap
130.55M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.83M-1.23M-11.13%
Aug 31, 202511.06M-213.75K-1.90%
Aug 31, 202411.28M-2.68M-19.18%
Aug 31, 202313.96M7.73M124.03%
Aug 31, 20226.23M1.77M39.82%
Aug 31, 2021 Pro Pro Pro
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Magle Chemoswed Holding AB287.55M
IRLAB Therapeutics AB92.46M
Nanologica AB21.13M
Scandinavian ChemoTech AB12.61M
Biovica International AB10.93M
Elicera Therapeutics AB10.64M
AcouSort AB10.43M
Simris Group AB (PUBL)2.65M
Revenue Rankings

NextCell Pharma AB News

More News